Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?

The aim of the present study was to evaluate whether prostate cancer (PC) patients can be accurately classified on the bases of tissue expression of gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA). This retrospective study included 28 patients with PC. Formali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Faviana, Pinuccia, Boldrini, Laura, Erba, Paola Anna, Di Stefano, Iosè, Manassero, Francesca, Bartoletti, Riccardo, Galli, Luca, Gentile, Carlo, Bardi, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039448/
https://ncbi.nlm.nih.gov/pubmed/33854977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.650249
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados